Cargando…
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based study
Fibrolamellar hepatocellular carcinoma (FLC) is a rare primary liver cancer that affects primarily adolescents and young adults. It is associated with a poor overall prognosis. There is a need to better define risk factors, but small sample size has limited such studies. An FLC patient registry now...
Autores principales: | Berkovitz, Amichai, Migler, Rachael D., Qureshi, Adam, Rosemore, Carly, Torbenson, Michael S., Vaughan, Roger, Marcotte, Erin, Simon, Sanford M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701473/ https://www.ncbi.nlm.nih.gov/pubmed/36245434 http://dx.doi.org/10.1002/hep4.2105 |
Ejemplares similares
-
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022) -
Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012) -
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma
por: Levin, Solomon N., et al.
Publicado: (2023) -
Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
por: Chen, Krista Y., et al.
Publicado: (2022) -
Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA
por: Neumayer, Christoph, et al.
Publicado: (2023)